封面
市場調查報告書
商品編碼
1790321

美國法醫學基因組學市場規模、佔有率和趨勢分析報告:按產品、方法、應用和細分市場預測,2025 年至 2033 年

U.S. Forensic Genomics Market Size, Share & Trends Analysis Report By Product (Software, Consumables & Kits), By Method (NGS, PCR Amplification), By Application (Criminal Testing, Paternity & Familial Testing), And Segment Forecasts, 2025 - 2033

出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國法醫學基因組學市場規模與趨勢

預計 2024 年美國法醫學基因組學市場規模為 2.565 億美元,到 2033 年將達到 9.41 億美元,2025 年至 2033 年的複合年成長率為 15.65%。

這一成長得益於基因組技術的進步、法醫學DNA分析在刑事調查中的應用日益廣泛,以及政府對法醫學研究和基礎設施建設的投入不斷增加。此外,執法和法律訴訟中對精準快速識別方法的需求日益成長,預計將在預測期內推動市場擴張。

犯罪率上升,調查複雜度增加

犯罪活動(尤其是暴力犯罪、性侵犯和兇殺案)的不斷增加是推動法醫學基因組學市場成長的主要因素之一。隨著刑事案件數量和複雜性的增加,對能夠提供準確可靠證據的先進工具的需求也日益成長。法醫學基因組學使執法機構能夠以高度詳細的基因水平分析生物樣本,與傳統法醫學方法相比,它在識別嫌疑人和分析受害者方面具有更高的準確性。

此外,隨著懸案和未破案件的增多,執法機構正在利用最新的基因組技術重新審查已存檔的證據,從而取得突破性發現並最終解決案件。對加快調查速度的需求以及減少冤假錯案的壓力進一步凸顯了法醫學基因組學在現代刑事司法體系中的重要性。這些因素共同導致了美國各地對法醫學應用中基因組解決方案的需求持續成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 產業分析工具
    • 依因素(政治/法律、經濟/技術)進行 SWOT 分析
    • 波特五力分析

第4章美國法醫學基因體學市場:產品業務分析

  • 產品細分儀表板
  • 美國法醫學基因組學市場:產品差異分析
  • 2021 年至 2033 年美國法醫學基因體學市場規模及趨勢分析(依產品)
  • 分析器和序列器
  • 軟體
  • 套件和耗材

第5章美國法醫學基因體學市場:方法論業務分析

  • 方法論細分儀表板
  • 美國法醫學基因體學市場:方法變異分析
  • 美國法醫學基因組學市場規模和趨勢分析(按方法論),2021 年至 2033 年
  • 毛細管電泳
  • 下一代定序
  • PCR擴增
  • 其他

第6章美國法醫學基因體學市場:應用商業分析

  • 應用程式細分儀表板
  • 美國法醫學基因體學市場:應用變異分析
  • 美國法醫學基因體學市場規模及應用趨勢分析(2021-2033)
  • 刑事測試
  • 親子鑑定和家庭檢測
  • 其他

第7章 競爭態勢

  • 參與企業
  • 戰略地圖
  • 2024年企業市場分析
  • 參與企業概況
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Agilent Technologies
    • Promega Corporation
    • QIAGEN
    • Bio-Rad Laboratories
    • LGC Limited
    • Tri Tech Forensics
    • Verogen
Product Code: GVR-4-68040-690-7

U.S. Forensic Genomics Market Size & Trends:

The U.S. forensic genomics market size was estimated at USD 256.5 million in 2024 and is projected to reach USD 941.0 million by 2033, expanding at a CAGR of 15.65% from 2025 to 2033. This growth is driven by advancements in genomic technologies, increasing adoption of forensic DNA analysis in criminal investigations, and rising government funding for forensic research and infrastructure. Moreover, the growing need for accurate and rapid identification methods in law enforcement and legal proceedings will fuel market expansion throughout the forecast period.

Increasing Crime Rates and Complexity of Investigations

Rising incidence of criminal activity, particularly violent crimes, sexual assaults, and homicides, is one of the primary drivers of the growth in the forensic genomics market. As the volume and complexity of criminal cases increases, there is a greater need for advanced tools to provide accurate and reliable evidence. Forensic genomics enables law enforcement agencies to analyze biological samples at a highly detailed genetic level, offering superior accuracy in suspect identification and victim profiling compared to traditional forensic methods.

Moreover, the growing number of unresolved and cold cases has prompted agencies to revisit archived evidence using modern genomic techniques, leading to breakthroughs and case resolutions. The demand for rapid turnaround in investigations and pressure to minimize wrongful convictions further underscores the importance of forensic genomics in the modern criminal justice system. These factors collectively contribute to sustained and increasing demand for genomic solutions in forensic applications across the U.S.

U.S. Forensic Genomics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. forensic genomics market report based on product, method, and application:

  • U.S. Forensic Genomics Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Analyzers & Sequencers
  • Software
  • Kits & Consumables
  • U.S. Forensic Genomics Method Outlook (Revenue, USD Million, 2021 - 2033)
  • Capillary Electrophoresis
  • Next-generation Sequencing
  • PCR Amplification
  • Others
  • U.S. Forensic Genomics Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Criminal Testing
  • Paternity & Familial Testing
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Method Segment
    • 1.2.3. Application Segment
  • 1.3. Information Analysis
    • 1.3.1. Market Formulation & Data Visualization
  • 1.4. Data Validation & Publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising government funds and initiatives for forensic programs
      • 3.3.1.2. Increasing crime rates
      • 3.3.1.3. Technological advancements in paternity & familial testing
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. High cost of equipment
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis

Chapter 4. U.S. Forensic Genomics Market: Product Business Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Forensic Genomics Market: Product Movement Analysis
  • 4.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Analyzers & Sequencers
    • 4.4.1. Analyzers & Sequencers Market, 2021 - 2033 (USD Million)
  • 4.5. Software
    • 4.5.1. Software Market, 2021 - 2033 (USD Million)
  • 4.6. Kits & Consumables
    • 4.6.1. Kits & Consumables Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Forensic Genomics Market: Method Business Analysis

  • 5.1. Method Segment Dashboard
  • 5.2. U.S. Forensic Genomics Market: Method Movement Analysis
  • 5.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
  • 5.4. Capillary Electrophoresis
    • 5.4.1. Capillary Electrophoresis Market, 2021 - 2033 (USD Million)
  • 5.5. Next-generation Sequencing
    • 5.5.1. Next-generation Sequencing Market, 2021 - 2033 (USD Million)
  • 5.6. PCR Amplification
    • 5.6.1. PCR Amplification Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Forensic Genomics Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. U.S. Forensic Genomics Market: Application Movement Analysis
  • 6.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Criminal Testing
    • 6.4.1. Criminal Testing Market, 2021 - 2033 (USD Million)
  • 6.5. Paternity & Familial Testing
    • 6.5.1. Paternity & Familial Testing Market, 2021 - 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Participant's Overview
    • 7.4.1. Illumina, Inc.
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Thermo Fisher Scientific, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Agilent Technologies
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Promega Corporation
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. QIAGEN
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Bio-Rad Laboratories
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LGC Limited
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Tri Tech Forensics
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Verogen
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Forensic Genomics Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Forensic Genomics Market, by Method, 2021 - 2033 (USD Million)
  • Table 5 U.S. Forensic Genomics Market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. forensic genomics market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segments snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 U.S. forensic genomics market value, 2024 (USD million)
  • Fig. 16 Market trends & outlook
  • Fig. 17 PESTEL analysis
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 U.S. Forensic Genomics Market: Product Key Takeaways
  • Fig. 20 U.S. Forensic Genomics Market: Product Movement Analysis
  • Fig. 21 U.S. Forensic Genomics Market, for Analyzers & Sequencers, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Forensic Genomics Market, for Software, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Forensic Genomics Market, for Kits & Consumables, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Forensic Genomics Market: Method Key Takeaways
  • Fig. 25 U.S. Forensic Genomics Market: Method Movement Analysis
  • Fig. 26 U.S. Forensic Genomics Market, for Capillary Electrophoresis, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Forensic Genomics Market, for Next-generation Sequencing, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Forensic Genomics Market, for PCR Amplification, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Forensic Genomics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Forensic Genomics Market: Application Key Takeaways
  • Fig. 31 U.S. Forensic Genomics Market, Application Movement Analysis
  • Fig. 32 U.S. Forensic Genomics Market, for Criminal Testing, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Forensic Genomics Market, for Paternity & Familial Testing, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Forensic Genomics Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 35 Strategic framework